ALT5 Sigma (NASDAQ:AIFC) Stock Price Up 1.6% – Should You Buy?

ALT5 Sigma Corporation (NASDAQ:AIFC)’s stock price was up 1.6% during mid-day trading on Thursday . The company traded as high as $0.5632 and last traded at $0.5565. 336,280 shares were traded during trading, a decline of 72% from the average daily volume of 1,219,385 shares. The stock had previously closed at $0.5480.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded ALT5 Sigma from a “sell” rating to a “strong sell” rating in a report on Saturday, April 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

ALT5 Sigma Price Performance

The firm’s fifty day moving average price is $0.75 and its two-hundred day moving average price is $1.20. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03.

ALT5 Sigma (NASDAQ:AIFC) last issued its earnings results on Monday, May 18th. The company reported ($2.14) earnings per share (EPS) for the quarter. ALT5 Sigma had a negative return on equity of 68.25% and a negative net margin of 2,483.94%.The company had revenue of $4.71 million during the quarter.

Hedge Funds Weigh In On ALT5 Sigma

A number of institutional investors and hedge funds have recently modified their holdings of AIFC. Private Advisor Group LLC increased its position in ALT5 Sigma by 138.0% during the first quarter. Private Advisor Group LLC now owns 94,857 shares of the company’s stock valued at $105,000 after acquiring an additional 55,000 shares during the last quarter. SG Americas Securities LLC lifted its holdings in ALT5 Sigma by 267.1% in the first quarter. SG Americas Securities LLC now owns 367,150 shares of the company’s stock valued at $408,000 after acquiring an additional 267,150 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in ALT5 Sigma by 237.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 123,577 shares of the company’s stock worth $136,000 after purchasing an additional 86,997 shares during the last quarter. Aristides Capital LLC purchased a new position in ALT5 Sigma in the fourth quarter worth about $155,000. Finally, XTX Topco Ltd grew its stake in shares of ALT5 Sigma by 298.9% during the 4th quarter. XTX Topco Ltd now owns 489,500 shares of the company’s stock valued at $538,000 after purchasing an additional 366,801 shares during the period. 6.27% of the stock is currently owned by hedge funds and other institutional investors.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.